Outcome of Vaginal Progesterone as a Tocolytic Agent: Randomized Clinical Trial

Table 2

Comparison of maternal outcomes between two groups of patients.

Parameters	Progesterone group (𝑁=72)	No-drug group (𝑁=72)	𝑃 value
Mean gestational age at delivery ± SD (year)	36.2±1.4	34.1±1.5	0.039
Mean time of postponing delivery ± SD (week)	4.0±1.5	1.4±0.2	0.048
Mean of cervical length and dilatation ± SD	1.8±0.3	1.7±0.4	0.71
Mean of cervical length and dilatation ± SD	1.5±0.2	1.6±0.3	0.92
Type of delivery (Cesarean/NVD)	16/56	19/53	0.058